Endogenous asymmetrical dimethylarginine and hypertension associated with puromycin nephrosis in the rat

British Journal of Pharmacology

Volumn 125, Issue 3, 1998, Pages 469-476

  Sato, Jun ^a   Masuda, Hiroshi ^a   Tamaoki, Satoru ^a   Hamasaki, Hidehisa ^a   Ishizaka, Kazuhiro ^b   Matsubara, Osamu ^c   Azuma, Hiroshi ^a  

^a Tokyo Medical and Dental University ^*  (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

ADMA; Endogenous NOS inhibitor; FSGS; Hypertension; Puromycin

Indexed keywords

ACETYLCHOLINE; CREATININE; CYCLIC GMP; N(G) METHYLARGININE; NITRIC OXIDE; NORADRENALIN; PROTAMINE; PROTEIN; PUROMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY WALL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE CLEARANCE; GLOMERULUS CAPILLARY; HYPERTENSION; MALE; MESANGIUM; NEPHROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; SYSTOLIC BLOOD PRESSURE; UNINEPHRECTOMY; URINE VOLUME; VASCULAR ENDOTHELIUM;

ANIMALS; ARGININE; BLOOD PRESSURE; BODY WEIGHT; CYCLIC GMP; ENDOTHELIUM; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HYPERTENSION; KIDNEY; MALE; NITROUS OXIDE; PUROMYCIN AMINONUCLEOSIDE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031679479     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702101     Document Type: Article

References (44)

1. G-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea-pig: Does nitric oxide regulate blood pressure in vivo? Biochem. Biophys. Res. Commun., 160, 881-886.
2. AZUMA, H., MASUDA, H., SATO, J., NIWA, K. & TOKORO, T. (1997). A possible role of endogenous inhibitor for nitric oxide synthesis in the bovine ciliary muscle. Exp. Eye Res., 64, 823-830.
3. AZUMA, H., SATO, J., HAMASAKI, H., SUGIMOTO, A., ISOTANI, E. & OBAYASHI, S. (1995). Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells. Br. J. Pharmacol., 115, 1001-1004.
4. BALDWIN, D.S. (1982). Chronic glomerulonephritis: Nonimmunologic mechanisms of progressive glomerular damage. Kidney Int., 21, 109-114.
5. BODE-BOGER, S.M., BÖGER, R.H., KIENKE, S., JUNKER, W. & FROLICH, J.C. (1996). Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem. Biophys. Res. Commun., 219, 598-603.
6. G-monomethyl-L-arginine uptake: a mechanism for differential inhibition of NO synthase? Am. J. Physiol., 269, C750-C756.
7. BRENNER, B.M., MEYER, T.W. & HOSTETTER, T.H. (1982). Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation and intrinsic renal disease. N. Engl. J. Med., 307, 652-659.
8. CHU, A., CHAMBERS, D.E., LIN, C.-C., KUEL, W.D. & COBB, F.R. (1990). Nitric oxide modulates epicardial coronary basal vasomotor tone in awake dogs. Am. J. Physiol., 258, H1250-H1254.
9. DIAMOND, J.R. & KARNOVSKI, M.J. (1986). Focal and segmental glomerulosclerosis following a single intravenous dose of puromycin aminonucleoside. Am. J. Pathol., 122, 481-487.
10. EBIHARA, L. NAKAMURA, T., FLIKUI, M., YAGUCHI, Y. & KOIDE, H. (1993). Extracellular matrix component mRNA expression in glomerulus in experimental focal glomerulosclerosis. J. Am. Soc. Nephrol., 3, 1387-1397.
11. G-dimethylarginine by human endothelial cells. Endothelium. 1, 137-140.
12. GARDINER, S.M., COMPTON, A.M., PALMER, R.M.J. & MONCADA, S. (1990). Control of regional blood flow by endothelium-derived nitric oxide. Hypertension, 15, 486-492.
13. GLASSER, R.J., VELOSA, J.A. & MICHAEL, A.F. (1977). Experimental model of focal sclerosis. 1. Relationship to protein excretion in aminonucleoside nephrosis. Lab. Invest., 36, 519-526.
14. GROND, J., WEENING, J.J. & ELEMA, J.D. (1984). Glomerular sclerosis in nephrotic rats. Comparison of the long term effects of adriamycin and aminonucleoside. Lab. Invest., 51, 277-285.
15. G-methylarginine. Biochem. Biophys. Res. Commun., 170, 96-103.
16. HAMASAKI, H., SATO, J., MASUDA, H., TAMAOKI, S., ISOTANI, E., OBAYASHI, S., UDAGAWA, T. & AZUMA, H. (1997). Effect of nicotine on the intimal hyperplasia after endothelial removal of (he rabbit carotid artery. Gen. Pharmacol., 28, 653-659.
17. G-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine. Biochem. Biophys. Res. Commun., 167, 1037-1043.
18. HONMA, M., SATOH, T., TAKEZAWA, J. & UI, M. (1977). An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue. Biochem. Med., 18, 257-273.
19. IGNARRO, L.J. (1990a). Biosynthesis and metabolism of endothelium-derived nitric oxide. Ann. Rev. Pharmacol. Toxicol., 30, 535-560.
20. IGNARRO, L.J. (1990b). Nitric oxide: A novel signal transduction mechanism for transcellular communication. Hypertension. 16, 477-483.
21. ε-mono-. di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-δ-hydroxylysine from human urine. J. Biol. Chem., 245, 5751-5758.
22. G-dimethylarginine dimethylaminohydrolase in the nitric oxide generating systems of rats using monoclonal antibody. Arch. Biochem. Biophys., 300, 657-662.
23. KISSANE, J.M. & ROBINS, E. (1958). The fluorometric measurement of deoxyribonucleic acid in animal tissue with special reference to the central nervous system. J. Biol. Chem., 233, 184-188.
24. KOBAYASHI, Y. & HATTORI, K. (1990). Nitroarginine inhibits endothelium-derived relaxation. Jpn. J. Pharmacol., 52, 167-169.
25. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
26. LUSCHER, T.F., BOCK, H.A., YANG, Z. & DIEDERICH, D. (1990). Endothelium-derived relaxing and contracting factors: Perspective in nephrology. Kidney Int., 39, 575-590.
27. MACALLISTER, R.J., PARRY, H., KIMOTO, M. OGAWA, T. RUSSELL, R.J., HUDSON, H., WHITLEY, G.ST.J. & VALLANCE, P. (1996). Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br. J. Pharmacol., 119, 1533-1540.
28. MACALLISTER, R.J. & VALLANCE, P. (1994). Nitric oxide in essential and renal hypertension. J. Am. Soc. Nephrol., 5, 1057-1065.
29. MACALLISTER, R.J., WHITLEY, G.St.J & VALLANCE, P. (1994). Effects of guanidino and uremic compounds on nitric oxide pathways. Kidney Int., 45, 737-742.
30. MATSUOKA, H., ITOH, S., KIMOTO, M., KOHNO, K., TAMAl, O., WADA, Y., YASUKAWA, H., IWAMI, G., OKUDA, S. & IMAIZUMI, T. (1997). Asymmetrical dimethylarginme, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension, 29, 242-247.
31. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1988). The discovery of nitric oxide as the endogenous nitrosovasodilator. Hypertension. 12, 365-372.
32. NAKAMURA, T., EBIHARA, I., FUKUI, M., OSADA, S., NAGAOKA, I., HORIKOSHI, S., TOMINO, Y. & KOIDE, H. (1993). Messenger RNA expression of growth factors in glomeruli from focal glomerular sclerosis. Clin. Immunol. Immunopathol., 66, 33-42.
33. G-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol. Chem., 264, 10205-10209.
34. G-dimethylurginine in rats. Arch. Biochem. Biophys., 252, 526-537.
35. PALMER, R.M.L. REES, D.D., ASHTON, D.S. & MONCADA, S. (1988). L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun., 153, 1251-1256.
36. RAPOPORT, R.M. & MURAD, F. (1983). Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cyclic GMP. Circ. Res., 52, 352-357.
37. REES, D.D., PALMER, R.M.J. & MONCADA, S. (1989). Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci., 86, 3375-3378.
38. SAITO, T., SUMITHRAN, E., GLASGOW, E.F. & ATKINS, R.C. (1987). The enhancement of aminonuclcoside nephrosis by the co-administration of protamine. Kidney Int., 32, 691-699.
39. TOEINS, J.P., PALMER, R.M.J. & MONCADA, S. (1990). Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am. J. Physiol., 258, H655-H662.
40. VALLANCE, P., COLLIER, J. & MONCAOA, S. (1989). Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 2, 997-1000.
41. VALLANCE, P., LEONE, A.M., CALVER, A., COLLIER, J. & MONCADA, S. (1992). Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet, 239, 572-575.
42. VELOSA, J. A., OLASSER, R.J., NEVINS, T.E. & MICHAEL, A. F. (1977). Model of focal sclerosis. II, Correlation with immunopathologic changes, macromolecular kinetics and polyanion loss. Lab. Invest., 36, 527-534.
43. WHITTLE, B.J.R, LOPEZ-BELMONTE, J. & REES, D.D. (1989). Modulation of the vasopressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br. J. Pharmacol., 98, 646-652.
44. YU, X.-J., LI, Y.-J. & XIONG, Y. (1994). Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits. Life Sci., 54, 753-758.